Featured Publications

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Expert Consensus Statements Emily Hoelscher Expert Consensus Statements Emily Hoelscher

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

Daniel E Soffer, Nicholas A Marston, Kevin C Maki, Terry A Jacobson, Jessica M Peña, George Thanassoulis, Seth S Martin, Carol F Kirkpatrick, Salim S Virani, Dave L Dixon, Christie M Ballantyne, Alan T Remaley

This National Lipid Association (NLA) Expert Clinical Consensus provides an overview of the physiologic and clinical considerations regarding the role of apolipoprotein B (apoB) measurement to guide clinical care based on the available scientific evidence and expert opinion.

Read More
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review
Expert Consensus Statements Emily Hoelscher Expert Consensus Statements Emily Hoelscher

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review

Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, Peter P Toth, Ryan T Morgan, Justin Tondt, Sandra Michelle Christensen, Dave L Dixon, Terry A Jacobson

This joint expert review by the Obesity Medicine Association (OMA) and National Lipid Association (NLA) provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.

Read More
Nutrition interventions for adults with dyslipidemia: A clinical perspective from the National Lipid Association
Expert Consensus Statements Emily Hoelscher Expert Consensus Statements Emily Hoelscher

Nutrition interventions for adults with dyslipidemia: A clinical perspective from the National Lipid Association

Carol F Kirkpatrick, Geeta Sikand, Kristina S Petersen, Cheryl A M Anderson, Karen E Aspry, Julie P Bolick, Penny M Kris-Etherton

Lifestyle habits can have a profound impact on atherosclerotic cardiovascular disease (ASCVD) risk. The National Lipid Association previously published recommendations for lifestyle therapies to manage dyslipidemia.

Read More